Cerebellar stroke in a low cardiovascular risk patient associated with sorafenib treatment for fibrolamellar hepatocellular carcinoma.

Vandewynckel, Yves-Paul; Geerts, Anja; Verhelst, Xavier; Van Vlierberghe, Hans

Vandewynckel, Yves-Paul; Geerts, Anja; Verhelst, Xavier; Van Vlierberghe, Hans.

Afiliación

Vandewynckel YP; Department of Hepatology and Gastroenterology, Ghent University B-9000, Ghent, Belgium.
Geerts A; Department of Hepatology and Gastroenterology, Ghent University B-9000, Ghent, Belgium.
Verhelst X; Department of Hepatology and Gastroenterology, Ghent University B-9000, Ghent, Belgium.
Van Vlierberghe H; Department of Hepatology and Gastroenterology, Ghent University B-9000, Ghent, Belgium.

Clin Case Rep ; 2(1): 4-6, 2014 Feb.

Article en En | MEDLINE | ID: mdl-25356226

Palabras clave

Carcinoma; drug toxicity; fibrolamellar hepatocellular carcinoma; hepatocellular; sorafenib; stroke

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Clin Case Rep Año: 2014 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google